NCT07349251 Normal Hemostasis Values in Premature Infants
| NCT ID | NCT07349251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Premature Infant, Hemostasis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-11-24 |
| Primary Completion | 2031-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-11-24 with a primary completion date of 2031-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter Exclusion Criteria: * Patients with incomplete data * Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07349251 clinical trial?
This trial is open to participants of all sexes, aged 0 Months or older, up to 18 Months, studying Premature Infant, Hemostasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07349251 currently recruiting?
Yes, NCT07349251 is actively recruiting participants. Contact the research team at agathe.herb@chru-strasbourg.fr for enrollment information.
Where is the NCT07349251 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07349251 clinical trial?
NCT07349251 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 1,000 participants.